Plus, utilities stocks that look promising and Pfizer’s stock prospects after $43 billion deal to buy a cancer drug developer. In today’s episode, Travis Miller, an energy and utilities strategist for Morningstar Research Services, discusses the potential earnings growth for the utilities sector, and which stocks are undervalued.
Why the Banking Crisis Is a Big Deal
